ChemoMetec develops and sells automated cell counting and analysis instruments used in cell therapy, bioprocessing and life-science research. Its NucleoCounter systems provide image-based cell counts and viability data that laboratories rely on for process control and quality. Customers include biotech and pharma organizations that need reproducible, regulatory-friendly cell analytics rather than purely manual microscopy.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 428.4 | — | 159.5 | — |
| 2023 | 444.4 | 3.7% | 178.7 | 12% |
| 2024 | 407.9 | -8.2% | 136.3 | -23.7% |
| 2025 | 495.6 | 21.5% | 186.4 | 36.8% |
All markets — KeepWinning global stock screener
Other companies on Copenhagen: DFDS A/S (DFDS), SJF Bank A/S (SJF), Gubra A/S (GUBRA), NTG Nordic Transport Group A/S (NTG), Scandinavian Tobacco Group A/S (STG), Boozt AB (publ) (BOOZT DKK)